InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.083 0.005 (6.41%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Appendix 2A - options 18 Jun 2020 8:50AM $0.190 $0.083 fallen by 56.32%
$26 Pro-rata Non-Renounceable Rights Issue Fully Allocated 15 Jun 2020 8:32AM $0.195 $0.083 fallen by 57.44%
$26 Rights Issue Close Date 9 Jun 2020 10:21AM $0.185 $0.083 fallen by 55.14%
$26 Webcast Overview of ASCO 2020 Annual Meeting NOX Posters 5 Jun 2020 10:42AM $0.195 $0.083 fallen by 57.44%
$26 Change of Director's Interest Notice - PM 4 Jun 2020 12:06PM $0.190 $0.083 fallen by 56.32%
$26 Change of Director's Interest Notice - ID 4 Jun 2020 12:03PM $0.190 $0.083 fallen by 56.32%
$26 Appendix 3G Adjustment to Option Exercise Prices 1 Jun 2020 2:04PM $0.215 $0.083 fallen by 61.40%
$26 ASCO 2020 Highlights NOX66 Potential in Late-Stage Cancer 1 Jun 2020 8:49AM $0.215 $0.083 fallen by 61.40%
$26 Listing Rule 6.22.2 Adjustment to Option Exercise Prices 28 May 2020 4:29PM $0.215 $0.083 fallen by 61.40%
$26 Proposed issue of Securities - NOX 22 May 2020 1:05PM $0.230 $0.083 fallen by 63.91%
$26 Despatch of Pro Rata Entitlement Offer Documents 21 May 2020 8:43AM $0.235 $0.083 fallen by 64.68%
$26 FDA allows Veyonda Pre-IND Submission for COVID-19 19 May 2020 2:14PM $0.195 $0.083 fallen by 57.44%
$26 Noxopharm ASCO Abstracts Live 14 May 2020 9:46AM $0.185 $0.083 fallen by 55.14%
$26 Appendix 2A 13 May 2020 6:53PM $0.185 $0.083 fallen by 55.14%
$26 Entitlement Offer Prospectus 13 May 2020 6:50PM $0.185 $0.083 fallen by 55.14%
$26 Entitlement Offer - Letter to Optionholders 13 May 2020 6:47PM $0.185 $0.083 fallen by 55.14%
$26 Entitlement Offer - Letter to Ineligible Shareholders 13 May 2020 6:45PM $0.185 $0.083 fallen by 55.14%
$26 Entitlement Offer - Letter to Eligible Shareholders 13 May 2020 6:44PM $0.185 $0.083 fallen by 55.14%
$26 Proposed issue of Securities - NOX 13 May 2020 10:47AM $0.195 $0.083 fallen by 57.44%
$26 $7.9 Million Fully Underwritten Entitlement Offer Announced 13 May 2020 10:46AM $0.195 $0.083 fallen by 57.44%
$26 Initial Director's Interest Notice - FB 8 May 2020 1:19PM $0.195 $0.083 fallen by 57.44%
$26 Appointment of New Board Member 8 May 2020 1:14PM $0.195 $0.083 fallen by 57.44%
$26 Trading Halt 7 May 2020 9:00AM $0.195 $0.083 fallen by 57.44%
$26 Change in substantial holding 1 May 2020 4:35PM $0.195 $0.083 fallen by 57.44%
$26 Change in substantial holding 1 May 2020 4:33PM $0.195 $0.083 fallen by 57.44%

401 - 425 of 794 results

Page 17 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.